What is a stock summary page? Click here for an overview.
Business Description
Harrow Inc
NAICS : 325412
SIC : 2834
ISIN : US45323A2015
Compare
Compare
Traded in other countries / regions
HROW.USA Index Membership
Russell 2000Russell 3000Russell 2000 IPO Date
2007-04-30Description
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.21 | |||||
| Equity-to-Asset | 0.18 | |||||
| Debt-to-Equity | 3.29 | |||||
| Debt-to-EBITDA | 11.44 | |||||
| Interest Coverage | 0.4 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 1.93 | |||||
| Beneish M-Score | -1 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 27.4 | |||||
| 3-Year EBITDA Growth Rate | 52.2 | |||||
| 3-Year EPS without NRI Growth Rate | 48.5 | |||||
| 3-Year FCF Growth Rate | -24.9 | |||||
| 3-Year Book Growth Rate | 67 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 48.43 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 44.09 | |||||
| 9-Day RSI | 46.47 | |||||
| 14-Day RSI | 46.15 | |||||
| 3-1 Month Momentum % | -29.47 | |||||
| 6-1 Month Momentum % | -48.48 | |||||
| 12-1 Month Momentum % | 95.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.08 | |||||
| Quick Ratio | 1.96 | |||||
| Cash Ratio | 0.52 | |||||
| Days Inventory | 77.02 | |||||
| Days Sales Outstanding | 105.07 | |||||
| Days Payable | 175.23 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -9.8 | |||||
| Shareholder Yield % | -2.1 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 75.33 | |||||
| Operating Margin % | 4.55 | |||||
| Net Margin % | -8.76 | |||||
| FCF Margin % | -30.5 | |||||
| ROE % | -27.53 | |||||
| ROA % | -5.28 | |||||
| ROIC % | 4.59 | |||||
| 3-Year ROIIC % | 3.42 | |||||
| ROC (Joel Greenblatt) % | 19.66 | |||||
| ROCE % | 2.06 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 45.4 | |||||
| PS Ratio | 4.27 | |||||
| PB Ratio | 12.28 | |||||
| EV-to-EBIT | 203.08 | |||||
| EV-to-EBITDA | 55.49 | |||||
| EV-to-Revenue | 5.56 | |||||
| EV-to-Forward-Revenue | 3.97 | |||||
| EV-to-FCF | -18.23 | |||||
| Price-to-GF-Value | 0.92 | |||||
| Price-to-Median-PS-Value | 1.28 | |||||
| Earnings Yield (Greenblatt) % | 0.49 | |||||
| FCF Yield % | -7.1 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:HROW
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Harrow Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 199.614 | ||
| EPS (TTM) ($) | -0.49 | ||
| Beta | -0.27 | ||
| 3-Year Sharpe Ratio | 0.85 | ||
| 3-Year Sortino Ratio | 1.74 | ||
| Volatility % | 104.88 | ||
| 14-Day RSI | 46.15 | ||
| 14-Day ATR ($) | 2.175 | ||
| 20-Day SMA ($) | 25.7195 | ||
| 12-1 Month Momentum % | 95.65 | ||
| 52-Week Range ($) | 9.86 - 59.23 | ||
| Shares Outstanding (Mil) | 35.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Harrow Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Harrow Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Harrow Inc Frequently Asked Questions
What is Harrow Inc(HROW)'s stock price today?
The current price of HROW is $24.04. The 52 week high of HROW is $59.23 and 52 week low is $9.86.
When is next earnings date of Harrow Inc(HROW)?
The next earnings date of Harrow Inc(HROW) is 2025-05-14 Est..
Does Harrow Inc(HROW) pay dividends? If so, how much?
Harrow Inc(HROW) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers